Cannabics Pharmaceuticals Stock Today
| CNBX Stock | USD 0.01 0.00 0.00% |
Performance3 of 100
| Odds Of DistressOver 86
|
Cannabics Pharmaceuticals is trading at 0.01 as of the 2nd of December 2024; that is No Change since the beginning of the trading day. The stock's open price was 0.01. Cannabics Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Cannabics Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. The company has 1.26 M outstanding shares. More on Cannabics Pharmaceuticals
Moving against Cannabics Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cannabics Pink Sheet Highlights
| Business Concentration | Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Cannabics Pharmaceuticals [CNBX] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 123.28 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cannabics Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cannabics Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cannabics Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.26 M outstanding shares.
Cannabics Pharmaceuticals currently holds about 96.28 K in cash with (1.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cannabics Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationCannabics Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Cannabics Ownership Details
Cannabics Pharmaceuticals Risk Profiles
| Mean Deviation | 2.17 | |||
| Standard Deviation | 8.61 | |||
| Variance | 74.15 | |||
| Risk Adjusted Performance | 0.0447 |
Cannabics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cannabics Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Cannabics Pharmaceuticals Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Gabriel Yariv | COO Pres | Profile | |
| Tal Mofkadi | Financial Board | Profile | |
| Sanja Goldberg | Chief Officer | Profile | |
| Sigalit ArielyPortnoy | Validation Regulation | Profile | |
| Ilya MD | Head Devel | Profile |
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.